Biogen Inc. is a Fortune 500 biotechnology company that specialises in research and development of treatments for neurological diseases. Over the years, the company has developed well-established medications for multiple sclerosis, plaque psoriasis, spinal muscular atrophy, and leukemia, and has research programs focused on other diseases such as Alzheimer’s and dementia.
The company achieved carbon neutrality in 2014, by matching 100% of their electricity usage with renewable energy, credits and offsets. In 2020, the company launched their Healthy Climate, Healthy Lives initiative which is a 20-year, $250 million commitment to eliminate fossil fuel emissions across all operations by 2040. The ambitious initiative marked it as the 1st Fortune 500 company to commit beyond net zero and become fossil fuel free. As part of their commitment, Biogen has tied a portion of their employees 2021 compensation to advancing their Environmental, Social and Governance (ESG) strategy.
Just last year in 2021, Biogen also joined the MIT Climate and Sustainability Consortium (MCSC), an alliance comprising of 16 sustainability leaders across sectors to establish processes and breakthrough strategies for environmental innovation. Some prominent companies within the alliance are Apple, Boeing, IBM and PepsiCo. Since then, the company has also embarked on other green initiatives from electric vehicle programs to establishing green Biogen labs.
Impressed by Biogen’s environmental commitment? Take a view on Biogen, trade Biogen stock on Phillip Nova. 在我们的地球日促销活动中,您将在 2022 年 4 月 1 日至 4 月 30 日期间交易任何 ESG 股票/ETF 获得 $100。在此处了解更多信息。
在 Phillip Nova 交易股票、ETF、外汇和期货
Phillip Nova 的交易特点
- 访问 20 多个全球交易所
从 20 多个全球交易所的 200 多个全球期货中捕捉机会
- 全球股票的交易机会
新加坡、中国、香港、马来西亚和美国市场的 11,000 多只股票和 ETF。
- 超过 90 项技术指标
使用 Phillip Nova 平台上的 90 多种技术指标,查看实时图表并轻松进行交易
- 在 Phillip Nova 上交易多种资产
您可以在 Phillip Nova 的单一账本上交易股票、ETF、外汇和期货